bpc-157 regulatory status fda warning 2024 2025 FDA's Overreach on Compounded Peptides RFK Jr pushes for FDA

RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA to discuss easing restrictions on peptides despite safety concerns US healthcare The Guardian

SKU: 10316313223 · From swhco.com